TERALITHE 250 mg, scored tablet 100 tablets
Active ingredients: Lithium carbonate, Lithium
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Scored tablet100 tabletsorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- TERALITHE 250 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 100 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES DELBERT
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1975
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62124478CIP73137633CIP133400931376330Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARBONATE DE LITHIUMcomprimé | 250 mg · un comprimé | SA |
| LITHIUMcomprimé | 6,8 mEq · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.